Clinicopathological features and prognosis of patients with HER2-low breast cancer
Abstract Background Low human epidermal growth factor receptor 2 (HER2) expression is an emerging concept in breast cancer that is defined as immunohistochemistry (IHC) 1 + or IHC 2 + and negative in situ hybridization (ISH) but has been poorly investigated. The aim of our study was to determine the...
Sparad:
| Huvudupphov: | , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2023-09-01
|
| Serie: | BMC Cancer |
| Ämnen: | |
| Länkar: | https://doi.org/10.1186/s12885-023-11421-0 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|